News

Beatrice Secures Indonesian Registration, Opening New Partnership Frontiers

Asia Expansion

2025 stands as the overseas debut year for CIMM. Following the approval of its medical device certification in Indonesia, CIMM achieves another milestone: Beatrice Hyaluronic Acid Sodium Gel for Injection has officially obtained Vietnam’s medical device registration. This marks a pivotal step in its Southeast Asian strategic layout and adds a new milestone to the brand’s globalization journey.

Vietnam: A Booming Hub in Southeast Asia’s Medical Aesthetics Market

As one of the fastest-growing beauty markets in Southeast Asia, Vietnam is rapidly emerging as Asia’s most promising hub for medical aesthetics consumption. Aligning with “Natural & Secure Beauty”, Vietnamese consumers’ focus on safety and technological excellence aligns seamlessly with Beatrice’s core philosophy of “Natural & Secure Beauty.” The product’s strengths include:

• Core Technology Advantages: Advanced preparation technology balancing high viscosity-elasticity and biocompatibility of the gel.
• Safety Assurance: Enhanced biocompatibility with cross-linking agent residues significantly below international standards.
• Precision Design: Customized solutions based on an Oriental aesthetic database, tailored to Asian facial features.

Seeking Global “Beauty Partners”

We sincerely welcome high-quality medical aesthetics institutions and reputable distributors to collaborate, aiming for mutual success and a shared new chapter in Southeast Asia’s medical aesthetics industry. For overseas cooperation inquiries contact us:marketing@czywyjs.com